Please ensure Javascript is enabled for purposes ofwebsite accessibility
Close Alert

FDA panel backs over-the-counter sales of birth control pill


This illustration provided by Perrigo in May 2023, depicts proposed packaging for the company's birth control medication Opill. (Perrigo via AP)
This illustration provided by Perrigo in May 2023, depicts proposed packaging for the company's birth control medication Opill. (Perrigo via AP)
Facebook Share IconTwitter Share IconEmail Share Icon
Loading ...